- Research
- Open access
- Published:
Associations between triglyceride-glucose index combined with waist circumference and heart failure in individuals with different body mass indices: a cross-sectional study using NHANES 2011–2020 data
Lipids in Health and Disease volume 24, Article number: 87 (2025)
Abstract
Introduction
The incidence of heart failure (HF), a cardiovascular disease, has been widely reported to be gradually increasing. Although the triglyceride-glucose (TyG) index is associated with the risk of HF, this relationship may be affected by differences in nutritional status among individuals with varying levels of obesity. Waist circumference combined with the TyG index may be more accurately associated with HF.
Methods
This study analyzed data from 8769 participants from the 2011–2020 National Health and Nutrition Examination Survey (NHANES). After weighting the data, multivariable logistic regressions were used to calculate the associations between HF and the TyG and TyG-waist circumference (TyG-WC) indices in adults with different body mass indices (BMIs). Restricted cubic splines were employed to assess for linear or nonlinear relationships. Receiver operating characteristic (ROC) curves were used to demonstrate the efficacy of the models for different indices. The Net Reclassification Index (NRI) was used to measure the improvement in the TyG-WC index relative to the TyG index in the different models. The Integrated Discriminant Improvement Index (IDI) supports this conclusion.
Results
TyG and TyG-WC indices were positively associated with HF (TyG: odds ratio [OR], 1.765; 95% CI], 1.390–2.242; P < 0.001; TyG-WC: OR, 1.003; 95% CI, 1.002–1.004; P < 0.001), except In Model 4 for the TyG index (OR, 1.238; 95% CI, 0.941–1.629; P = 0.124). BMI was used to categorize the study population into normal or underweight and overweight or obese groups. In the overweight and obese groups, the odds ratio (OR) increased as the index value increased. However, in the normal and underweight groups, high TyG indices were associated with low ORs. According to the ROC, NRI, and IDI analyses, the TyG-WC index was associated with HF in the normal weight or underweight groups (area under the curve [AUC]: 0.6724; 95% CI: 0.4991-0.6400), whereas the TyG index alone was not (AUC: 0.5695; 95% CI: 0.6115–0.7334). In Model 4, adjusted for all covariates, the TyG index had a slightly better ability than the TyG-WC index (NRI: -0.4112; 95% CI: -0.6818- -0.1406; P < 0.05; IDI: -0.0072; 95%CI: -0.0228-0.0083; P = 0.36256). In the overweight and obese populations, the TyG-WC index was slightly better than the TyG index (NRI: 0.3089; 95% CI: 0.1726–0.4451; P < 0.001; IDI: 0.0084; 95% CI: 0.0017–0.0151; P < 0.05). However, the sensitivity of the TyG-WC index alone was only 41.8%.
Discussion
The association between HF and these two indices was influenced by BMI. In normal-weight and underweight populations, higher TyG indices may imply improved nutritional status. Therefore, the TyG index should be combined with WC to assess the risk of HF. In overweight or obese populations, both indices can be used to assess the risk of HF; however, the TyG-WC index is less sensitive when used alone.
Introduction
Heart failure (HF) is a prevalent disease worldwide. Recently, HF with preserved ejection fraction (HFpEF) has become common [1]. Conversely, the quantity of HF with reduced ejection fraction (HFrEF) has remained stable or declined [2]. HF morbidity has either settled or declined [3]. The prognosis of patients with HF has improved, but the mortality and healthcare burden remain high [4]. Accurate recognition and careful assessment of changes in patient indicators and their association with HF are critical in clinical practice.
Approximately 30–40% of patients with HF whether ejection fraction is decreased or preserved develop type 2 diabetes (T2DM) as a complication [1]. T2DM increases the all-cause mortality in HF [5]. However, T2DM is often overlooked in patients with HF. Therefore, the association between these two diseases is important. T2DM is strongly associated with insulin resistance (IR). In recent years, clinicians have often used the homeostasis model assessment for insulin resistance (HOMA-IR) index to assess IR. However, in patients managed with insulin or with complete loss of pancreatic β-cell function, the value of HOMA-IR assessment is limited [6]. The formula for the TyG index is TyG = ln (triglyceride × fasting plasma glucose/2), which addresses this limitation to a certain extent. Studies have shown that it is an influencing factor for outcomes in patients with cardiovascular diseases (CVD) with or without diabetes mellitus, suggesting that the TyG index has valuable applications for clinicians [7]. Zhang et al. studied data from 615 patients with cardiovascular disease who had diabetes or prediabetes. The study showed that the baseline TyG index had a U-shaped relationship with all-cause and CVD-related deaths. Before and after the threshold, the TyG index was strongly associated with mortality in patients with cardiovascular disease [8]. In addition, Zhu et al. studied a cohort of 2,033 patients with hypertension. They found a nonlinear relationship between the TyG index and the development of chronic kidney disease after 31 months of follow-up. The hazard ratio decreased until TyG was approximately 8.94 and then increased rapidly. This study showed that the TyG index is strongly associated with cardiovascular and kidney diseases [9].
In recent years, interest in fat distribution has gradually increased. In their review, Powell-Wiley et al. highlighted that recent studies suggested that waist circumference, which determines the degree of abdominal obesity, is an indicator of cardiovascular disease risk, independent of body mass index (BMI) [10]. Dang et al. demonstrated that the TyG-WC index (TyG-WC = TyG × WC) improved the prediction of CVD prognosis and mortality. In addition, their data suggested that the TyG-WC might be an effective indicator for recognizing people with CVD earlier and facilitating complete risk stratification [11]. Hu et al. included 2224 Chinese patients with hypertension and no history of myocardial infarction. After 7.15 years of follow-up, they found that TyG-WC was positively associated with the risk of the first myocardial infarction [12].
The TyG and TyG-WC indices can be influenced by many factors when analyzing their associations with cardiovascular disease outcomes. Few studies have selected these as stratification factors for subgroup analyses. In addition, few studies have examined the association between these two indices and HF. In this study, associations between the two indices and HF were analyzed across various models for subgroups classified by the BMI which was chosen from the subgroup analysis. In addition, TyG and TyG-WC were compared using accurate methods such as the NRI and IDI to provide clarification for clinicians in selecting indices for HF observation.
Methods
Screening of study participants
Data from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2020 were included. The NHANES database can be used to assess the nutritional status of individuals in the United States. Demographic, clinical, laboratory, and questionnaire data were collected. Demographic characteristics, WC, weight, height, fasting glucose level, triglyceride level, and other indicators that may affect the outcome were selected for analysis.
Different participants had different missing data points. These were related to other variables; therefore, they could not be filled in with the median. Predicting missing data for each participant is extremely tedious. Considering that a large sample size remained after excluding those with missing data, participants with missing data on HF, TyG index, WC, weight, or other covariates were excluded. Furthermore, based on the screening methods for American adults from the NHANES in published articles [13, 14], participants younger than 20 years were excluded. Disease diagnoses were binary variables; therefore, those whose responses to questions regarding disease diagnoses were unclear were excluded. Participants without weighted data were excluded. Ultimately, 8769 participants were enrolled in the study. A flowchart of the screening process is shown in Fig. 1.
Variable selection
Questions from the medical conditions section of the questionnaire data were utilized to diagnose HF. People who answered yes to MCQ160b —Ever told you had congestive heart failure— were identified as having had HF. The TyG index required manual calculation, using the LBXTR-triglyceride and LBXGLU-fasting glucose laboratory data from the NHANES database. TyG was categorized into tertiles Q1-TyG, Q2-TyG, or Q3-TyG. To calculate TyG-WC, the BMXWAIST-waist circumference (cm) data from the body measures section were collected. TyG-WC was also categorized into tertiles Q1-TyG-WC, Q2-TyG-WC, or Q3-TyG-WC.
In addition, covariates that may have a significant impact on the outcome were integrated, including age, sex, race, education, income, BMI, and some biochemical indices such as indicators of lipid and glucose metabolism, as well as data on complications such as diabetes and cardiovascular diseases.
BMI values referenced the BMXBMI-body mass index (kg/m^2) examination data and the populations were classified using BMI into two groups, the normal or thin and the overweight or obese group, respectively. Educational status was determined by the DMDEDUC2-education level-adults 20 or older demographic data. Income levels were determined using the INDFMPIR-ratio of family income to poverty levels from the demographic data, with the values of 0–4.98 categorized as low and 5 classified as high. Participants who answered yes to DIQ010, MCQ160f, BPQ020, MCQ160d, MCQ160c, or MCQ160e were considered to have diabetes, stroke, hypertension, angina, coronary heart disease, or myocardial infarction, respectively.
Statistical analysis
R Studio (version 4.3.1) was used for analysis. P-values less than 0.05 were considered significant. The NHANES obtained samples through complex multistage sampling, and its recommendations were used to calculate the weights of the data. When baseline data were compared according to the classification of whether the participant had HF and two indices, χ2 or Fisher’s exact tests, the Mann–Whitney U or Kruskal–Wallis tests were used. Medians, along with the upper and lower quartiles, were used to represent the distribution of continuous variables. The counts and composition ratios are shown in the tables to represent the distribution of categorical variables.
Multivariable logistic regression analysis helped reveal the associations between the two indices and HF, and different models were constructed by including different covariants. The results are presented as odds ratios (ORs). Additionally, 95% confidence intervals (95% CI) were calculated. Continuous and categorical forms of TyG and TyG-WC were used as variables to construct the models. Model 1 did not incorporate any adjustment factors, whereas model 2 integrated demographic covariates, including age, sex, race, education, and income. Model 3 incorporated cardiovascular diseases that are risk factors for HF. Model 4 incorporated all covariates in models 2 and 3 as adjustment factors, including age, sex, race, education, income, and associated cardiovascular diseases.
After generating the models, a subgroup analysis was used to explore the factors that might influence the association between the TyG or TyG-WC index and HF. The study participants were divided into two groups according to BMI. Multivariable logistic regression analysis was used to construct models with the TyG or TyG-WC index and HF risk for each group. Each group consisted of four models with adjustment factors applied as previously described.
Next, restricted cubic splines (RCS) were employed to explore the linear relationships between HF risk and the two indices. The nodes were selected as tertiles and the thresholds are marked in the figures. After that, the receiver operating characteristic (ROC) was used to compare the efficacy of the different models using the area under the curve (AUC). NRI and IDI were used to compare the efficacies of the four models of the two indices. The new models were established as the TyG-WC models. When the NRI or IDI was positive and the P-value was less than 0.05, the efficacy of the TyG-WC model was superior.
Results
Characteristics of baseline data of study subjects
Differences in multiple variables between the groups were analyzed to assess the baseline characteristics of the 8769 study participants.
Regarding HF, 8503 individuals did not have HF, whereas 266 did (Table 1). The HF group was older and had lower educational and income levels than the group without HF. Compared to participants without HF, participants with HF had a higher weight, BMI, fasting glucose level, triglyceride level, WC, glycosylated hemoglobin (HbA1c) level, and lower high-density lipoprotein (HDL) level. Notably, low-density lipoprotein (LDL) and total cholesterol (TC) levels were lower in the HF group, likely because the patients with HF were prescribed statins, which effectively controlled their LDL and TC levels. The number of patients with diabetes, myocardial infarction, hypertension, coronary artery disease, angina, or stroke was higher in the HF group. Moreover, the TyG and TyG-WC indices were significantly higher in the HF group.
When using the TyG index tertiles as categorical indicators (Table 2), the higher the TyG index, the older the study participants. In addition, the percentage of individuals with diabetes, myocardial infarction, hypertension, coronary heart disease, angina, and stroke was higher among those with an increased TyG index. When the TyG-WC index tertiles were used as categorical indicators (Table 3), the results were similar to those of the TyG index. The percentage of patients with HF increased with increasing TyG and TyG-WC indices.
Analysis of the baseline data demonstrated that patients with HF often had metabolic abnormalities. Both indices were higher in patients with HF, suggesting that they may be strongly associated with HF.
Relationships between the TyG index, TyG-WC index, and HF
As explained in the methods section, multivariable logistic regression was used to create models and calculate the ORs of the two indices for HF.
For the continuous TyG index in Model 1, with no variable adjustment, there was a positive association between the index and HF (OR, 1.765; 95% CI, 1.390–2.242; P < 0.001). The results were similar in model 2 after adjusting for demographic variables (OR, 1.385, 95% CI, 1.055–1.817, P < 0.05) and in model 3 after adjusting for comorbidities (OR, 1.308, 95% CI, 1.018–1.681, P < 0.05). However, in model 4, which was adjusted for all variables, the results were not statistically significant (OR, 1.238; 95%CI, 0.941–1.629; P = 0.124). The categorical form was further analyzed, with the lowest tertile used as the reference. In the middle tertile, the ORs were not significantly higher in any of the four models. However, at the highest tertile, ORs were significantly increased in model 1 (OR, 2.518, 95% CI, 1.661–3.818, P < 0.001), model 2 (OR, 1.606, 95% CI, 1.061–2.431, P < 0.05) and model 3 (OR, 1.739, 95% CI, 1.110–2.725, P < 0.0). The ORs of model 4 in the highest tertile were higher than those in the middle tertile; however, the trend was not significant (OR, 1.487; 95% CI, 0.966–2.290; P = 0.0709). The results are presented as a forest plot (Fig. 2).
For continuous TyG-WC index, the index was positively associated with HF in model 1 (OR, 1.003, 95% CI, 1.002–1.004, P < 0.001), model 2 (OR, 1.003; 95% CI, 1.001–1.004, P < 0.001), model 3 (OR, 1.308, 95% CI, 1.018–1.681, P < 0.05) and model 4 (OR, 1.002, 95% CI, 1.001–1.004, P < 0.001). Next, we examined the association between the TyG-WC index and the risk of HF according to the TyG-WC tertiles. The first (lowest) tertile was used as the reference. In the middle tertile, the change in the OR was not significant for any of the four models. However, ORs were significantly higher for the highest TyG-WC tertile compared to the lower tertiles in model 1 (OR, 2.885, 95% CI, 1.892–4.401, P < 0.001), model 2 (OR, 1.694, 95% CI, 1.107–2.594, P < 0.05), model 3 (OR, 1.888, 95% CI, 1.245–2.862, P < 0.05) and model 4 (OR, 1.664, 95% CI, 1.087–2.548, P < 0.05). The results are presented as a forest plot (Fig. 3).
Analysis of subgroups with different BMIs
Subgroup analysis was used to assess possible variables affecting the association between the TyG index or TyG-WC index and HF. The results are shown in the two forest plots (Figs. 4 and 5). Race was an interaction factor for the two indices (P for interaction of the TyG index, 0.012; P for interaction of the TyG-WC index, 0.005), and education was an interaction factor for the TyG index (P for interaction of the TyG index, 0.022). BMI was not an interacting factor that could affect the association between the two indices and HF.
However, the TyG index was constructed primarily for normal individuals without considering the effect of nutritional status on metabolism. Low lipid and blood glucose levels are typically associated with malnutrition. Therefore, a high TyG level in a person with a low BMI may indicate good nutritional status. Using the TyG index alone to construct models for all participants may not be sufficiently accurate [15]. To further explore the efficacy of the two indices in reflecting the occurrence of HF in individuals with varying BMI, the study population was grouped according to BMI. The World Health Organization (WHO) categorized people as normal or thin (BMI < 25 kg/m2) and overweight or obese (BMI ≥ 25 kg/m2). Using a cutoff of 25 kg/m2, each group consisted of four models, with adjustment factors applied as previously described. The ORs between the indices and HF were calculated separately.
Among overweight or obese individuals, the ORs of the continuous TyG and TyG-WC indices were greater than 1 in all four models. When analyzing the categorical forms, the ORs of the middle tertile were not significantly increased in any of the four models compared with the reference tertile; however, in the highest tertile, the ORs were the highest. This indicates that the higher the TyG and TyG-WC indices, the higher the risk of HF in overweight or obese individuals. The statistical results are presented in Tables 4 and 5.
However, the associations among TyG, TyG-WC, and HF differed between normal and thin individuals. The OR of the continuous TyG index and HF was significant only in model 4, and the OR was less than 1 (OR, 0.406; 95% CI, 0.175–0.944; P < 0.05). Analysis of categorical TyG revealed that most of the results were not significant; however, the ORs gradually decreased or increased with decreasing or increasing TyG indices across the different models. This suggests that for normal or underweight populations, the risk of HF might be reduced with a high TyG index.
ORs of the continuous TyG-WC index were greater than 1 in model 1 and the result was significant (OR, 1.006; 95% CI, 1.003–1.008; P<0.001). Analysis of the categorical TyG-WC index revealed that although most results were not statistically significant, unlike the TyG index, the ORs increased when the TyG-WC index increased. This indicates that for normal or underweight individuals, the risk of HF increased as TyG-WC increased. The results are summarized in Table 5. results.
Analysis of RCS plots
RCS plots were used to assess the linear or nonlinear relationships between the two indices and HF (Figs. 6 and 7). In the baseline analysis, tertiles were chosen for categorization to reduce errors in the results for certain indicators. Therefore, when selecting the knots for the RCS plots, tertiles were selected as the three knots that were consistent with the baseline analysis.
The relationship between TyG and HF was linear only in models 1 and 3 (model 1, P = 0.7454; model 3, P = 0.3021). In models 2 and 4, the curves were J-and U-shaped, respectively. In model 4, the ORs for individuals who were normal or underweight decreased slightly, initially falling below 1. This trend indicates that the risk of HF decreased with increasing TyG when the BMI was < 25 kg/m2. In contrast, the ORs for overweight or obese individuals were greater than 1 and increased as the TyG index increased.
The relationship between TyG-WC and HF was linear in models 1, 3, and 4 (model 1, P = 0.1594; model 3, P = 0.7080; and model 4, P = 0.0539). In model 4, the ORs increased as the TyG-WC index increased across all BMI levels and were all greater than 1. This trend indicates that HF risk increased with increasing TyG-WC.
Using ROC, NRI, and IDI to compare models
The efficacy of the four models of the two indices was also measured using the AUC of the ROC and by calculating the cutoff value (Fig. 8). The AUC of the TyG index (continuous) was significant in models 2, 3, and 4 in normal and thin individuals (model 4: AUC, 0.9087; 95%CI, 0.8692–0.9482); however, the TyG index alone could not predict HF. The AUC calculated in the plot of the TyG-WC index (continuous) did not include 0.5 (significant) in all four models. The TyG-WC cut-off and sensitivity were 682.60%, 73.6%, and 53.8%, respectively.
ROC curves were used to assess the efficacy of models of the TyG and the TyG-WC index and calculate cutoff values. Figure A shows the ROC curves of the TyG index in four models for people with a BMI<25kg/m^2. Figure B shows the ROC curves of the TyG-WC index in four models for people with a BMI<25kg/m^2. Figure C shows the ROC curves of the TyG index in four models for people with a BMI 25kg/m≽2. Figure D shows the ROC curves of the TyG-WC index in four models for people with BMI 25kg /m≽2
In those with a BMI greater than or equal to 25 kg/m2, the AUC calculated in the plot of the TyG index (continuous) did not include 0.5 (significant) in all four models. The cutoff value was 8.78 (sensitivity, 51.2%; specificity, 61.6%). The AUC of the TyG-WC index (continuous) was significant in all the four models. The TyG-WC index cut-off was 1055.692, with a sensitivity of 41.8% and specificity of 41.8% and 82.8%, respectively. Among all the models, model 4 had the highest efficacy.
Results from the NRI and IDI supported that the TyG index alone was not as effective as the TyG-WC index to show an association with HF in normal or underweight populations and should be combined with other variations (Table 6), similar to the result from ROC. The TyG index exceeded the TyG-WC index in terms of the efficacy of the model adjusted for all covariates. In overweight and obese populations, the TyG-WC index showed a stronger association than TyG in all models. However, ROC and AUC analyses revealed that TyG-WC had a lower sensitivity when used alone (41.8%), based on its cutoff value.
Discussion
Based on the results, nutritional indices should be considered when analyzing their association with HF. Zhao et al. [16] suggested that the Nutritional Metabolic Risk Index could predict all-cause mortality in Americans. The better the nutritional status, the lower the risk of mortality. Another team from Japan [17] designed the ALIMENT-HF trial to assess the type of dietary supplements that could benefit outpatients. Thus, nutritional status is important and has garnered considerable attention.
BMI was used as a reference in this study. In the underweight and normal populations, the RCS curves suggested that the TyG index could protect people from HF within a certain range, and the curves were either U- or J-shaped. The ROC curves suggested that the TyG index alone was not associated with HF. Jiang et al. [18] suggested that when analyzing populations with malnutrition, a U-shaped relationship was observed in the RCS curves of TyG and HF. Furthermore, ROC, NRI, and IDI analyses suggested that TyG-WC alone may be better associated with HF when individuals are lean or of normal weight and that adjusting for demographics and comorbidities could help both indices predict HF accurately. Therefore, considering the TyG index and WC together could more accurately assess the risk of HF in individuals with a lower BMI.
In the overweight and obese populations, the ROC curves suggested that both indices had high efficacy after adjusting for confounders. Based on the NRI and IDI results, the TyG-WC index exceeded the TyG index in association with HF. However, the TyG-WC index in model 1 had a sensitivity of only 41.8%, suggesting that TyG-WC should not be used alone to demonstrate an association with HF.
WC was used as a complementary indicator to the TyG index, because WC measurements may assess obesity more accurately than the TyG index alone. Traditional methods of determining obesity using BMI alone may overlook the effects of fat distribution. Abdominal obesity is characterized by high levels of visceral fat. The WHO criteria considered an adult male with a WC of 90 cm or more or an adult female with a WC of 85 cm or more to have abdominal obesity [19]. Sherf-Dagan et al. [20] suggested that when selecting candidates for obesity treatment, emphasis should be placed on fat mass percentage and WC for diagnosing obesity rather than relying solely on BMI. Sweatt et al. [21] also demonstrated that while BMI is generally sufficient for diagnosing obesity, there are advantages to using WC to assess fat distribution. Therefore, fat metabolism should be considered while assessing glucose metabolism.
Other studies have demonstrated the value of TyG-WC and TyG indices. Khalaji et al. [22] included 30 studies in a systematic review with 772,809 participants. Compared to the lowest TyG group, the highest TyG group had a significantly increased risk of HF. The incidence of adverse events and mortality in patients were associated with TyG. Zheng et al. [23] used the NHANES database for their analysis, and the results showed that TyG, TyG-BMI, TyG-WC, and TyG-WHtR were significantly associated with chest pain. ROC curves showed that TyG-WC was the most robust and had the highest predictive value for coronary heart disease.
Glucose metabolism plays an important role in HF, and many recent studies have focused on it. Kato et al. [24] discovered that glucose metabolism could be improved by inhibiting the danamine-associated protein 1-fibronectin interaction and HF. Bei et al. [25] reported that inhibition of Hmbox1 in ischemia and reperfusion injury promotes glucose metabolism and HF, providing evidence for the prevention of myocardial injury after ischemia/reperfusion. Other metabolic scores for insulin resistance have been shown to predict cardiovascular or cerebrovascular events in patients with hypertension. A one-unit increase in the insulin resistance metabolic score is associated with a 30% increase in the risk of CVD events and a 27% increase in the risk of stroke [26]. Only ischemic stroke was significantly associated with this score [27].
Strengths and limitations
This study has several strengths. First, the associations between TyG, TyG-WC, and HF were identified. Second, this study focused on the effects of BMI on these variables. Participants with a low BMI and a high TyG index might indicate that the nutritional status of the person was better. This study identified two indicators associated with HF in individuals with varying levels of obesity. Third, ROC, NRI, and IDI analyses were used to assess the efficacy of the models of the indices, thereby improving the accuracy of the analysis. Additionally, these results provide insights for clinicians in selecting indices to assess the risk of HF. The TyG index is a classic metabolic index that is a predictor of many clinically important diseases. The TyG index is an important reference for cardiovascular diseases.
This study has some limitations. First, as this was a cross-sectional study, it was impossible to determine the sequence of causes and consequences. Furthermore, exploring whether both indices can predict the prognosis of patients with HF remains challenging. Therefore, it would be better to consider time factors in this study. Second, potential confounders cannot be avoided in cross-sectional studies. Possible confounders were incorporated while constructing the models, thereby strengthening the validity of the findings. However, as the main aim of this study was to analyze the relationship between different indices and HF, possible interactions were not considered when constructing the models, and this study did not achieve the aim of training more accurate models. Additionally, the study sample was limited to the United States. Extrapolating these results requires expanding the scope of this study to provide additional evidence.
Conclusion
The TyG and TyG-WC indices were associated with HF. When a patient’s BMI was categorized as normal weight or underweight, the TyG index was associated with HF when combined with demographic characteristics and comorbidities. The TyG-WC index also demonstrated greater accuracy when combined with additional information. In overweight or obese patients, both indices were associated with HF. However, the TyG-WC index had low sensitivity when used alone, making it unsuitable for use in predicting HF. Clinicians can refer to these results to select indices to assess the risk of HF. The TyG index should not be used alone to assess a BMI of 25 kg/m2 or less. Waist circumference should be considered also.
The relationship between metabolism and cardiovascular diseases has been widely discussed. Montaigne et al. [28] found that peroxisome proliferator-activated receptor-α (PPARα), PPARδ and PPARγ regulated lipoprotein metabolism, stimulated glucose utilization, stored triglycerides in lipid droplets, and increased insulin sensitivity. PPAR also resists the atherosclerotic and inflammatory processes. Therefore, fat metabolism plays an important role in HF. Wen et al. [29] found in a retrospective cohort study that a one-unit increase in the hepatic steatosis index increased the risk of major adverse cardiovascular events by 43%. Dalt et al. [30] found that, in patients with cardiomyopathy and heart failure, an imbalance between fatty acid intake and oxidation leads to changes in the main energy substrate, which is an important factor causing myocardial damage. The familiar and widely used drug semaglutide stimulates glycolysis and reduces mitochondrial damage, lipid accumulation, and energy deficiency, thereby improving heart function and reducing stress load in patients with HF [31].
In addition, researchers have broadened the scope of metabolic research in recent years. Attention to iron metabolism has gradually increased in recent years. Docherty et al. [32] analyzed 3009 patients and found that decreased transferrin saturation, ferritin level, increased total iron-binding capacity, and soluble transferrin receptors may influence the effect of dapagliflozin.
Future studies should focus on the effects of metabolism on HF. In-depth studies should focus on elucidating the mechanisms of metabolism in patients with HF and exploring accurate clinical prediction scores.
Data availability
All the data were downloaded directly from the National Health and Nutrition Examination Survey (NHANES).
References
Koh AS, et al. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2017;19(12):1624–34.
Owan TE, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–9.
Conrad N, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–80.
Savarese G, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–87.
Seferović PM, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853–72.
Minh HV, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich). 2021;23(3):529–37.
Tao LC, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.
Zhang Q, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018. Cardiovasc Diabetol. 2023;22(1):279.
Zhu Q, et al. The non-linear relationship between triglyceride-glucose index and risk of chronic kidney disease in hypertensive patients with abnormal glucose metabolism: a cohort study. Front Med (Lausanne). 2022;9:1018083.
Powell-Wiley TM, et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;143(21):e984–1010.
Dang K, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc Diabetol. 2024;23(1):8.
Hu J, et al. Association between triglyceride glucose Index-Waist circumference and risk of first myocardial infarction in Chinese hypertensive patients with obstructive sleep apnoea: an Observational Cohort Study. Nat Sci Sleep. 2022;14:969–80.
Zhang X, et al. Association between suicidal ideation and oxidative balance score (OBS): National Health and Nutrition Examination Survey (NHANES) 2005–2018. J Affect Disord. 2025;370:328–36.
Chen Y, et al. Association between flavonoid intake and rheumatoid arthritis among US adults. J Nutr Biochem. 2024;131:109673.
Mahmoudinezhad M, et al. Subjective global assessment of malnutrition and dysphagia effect on the clinical and para-clinical outcomes in elderly ischemic stroke patients: a community-based study. BMC Neurol. 2021;21(1):466.
Zhao C, et al. The nutritional metabolic risk index as a predictor of all-cause and cardiovascular mortality: a national cohort study. Clin Nutr ESPEN. 2024;63:391–9.
Fujimoto Y, et al. Oral nutritional supplements in older outpatients with heart failure: rationale and design of the ALIMENT-HF trial. ESC Heart Fail. 2024;11(4):2379–86.
Jiang X, et al. Association of triglyceride-glucose index with the prevalence of cardiovascular disease in malnourished/non-malnourished patients: a large cross-sectional study. Front Cardiovasc Med. 2023;10:1306415.
Jung S, et al. Association of the dietary inflammatory index with sarcopenic obesity and frailty in older adults. BMC Geriatr. 2024;24(1):654.
Sherf-Dagan S, Refaeli R, Buch A. Phenotyping of obesity treatment candidates: a narrative review. Curr Obes Rep. 2024;13(3):564–73.
Sweatt K, Garvey WT, Martins C. Strengths and limitations of BMI in the diagnosis of obesity: what is the path Forward? Curr Obes Rep. 2024;13(3):584–95.
Khalaji A, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.
Zheng D, et al. The association of triglyceride-glucose index and combined obesity indicators with chest pain and risk of cardiovascular disease in American population with pre-diabetes or diabetes. Front Endocrinol (Lausanne). 2024;15:1471535.
Kato Y et al. Inhibition of dynamin-related protein 1-filamin interaction improves systemic glucose metabolism. Br J Pharmacol, 2024.
Bei Y et al. Inhibition of Hmbox1 promotes cardiomyocyte survival and glucose metabolism through gck activation in Ischemia/Reperfusion Injury. Circulation, 2024.
Yang W, et al. The metabolic score for insulin resistance (METS-IR) predicts Cardiovascular Disease and its subtypes in patients with hypertension and obstructive sleep apnea. Clin Epidemiol. 2023;15:177–89.
Cai X, et al. Relationship of the metabolic score for insulin resistance and the risk of stroke in patients with hypertension: a cohort study. Front Endocrinol (Lausanne). 2022;13:1049211.
Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809–23.
Wen W, et al. Linear relationship between hepatic steatosis index and major adverse Cardiovascular events in hypertensive patients with obstructive sleep apnea: a real-world cohort study from China. Rev Cardiovasc Med. 2023;24(10):280.
Da Dalt L, et al. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovasc Res. 2023;119(10):1905–14.
Ma YL, et al. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis. Nat Commun. 2024;15(1):4757.
Docherty KF, et al. Iron Deficiency in Heart failure and effect of Dapagliflozin: findings from DAPA-HF. Circulation. 2022;146(13):980–94.
Funding
This work was supported by grants from the Beijing Natural Science Foundation (Grant Number 7222143), the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (CAMS Innovation Fund for Medical Science) (Grant Number 2020-I2M-1-002), and the High-level Hospital Clinical Research Fund of Fuwai Hospital, Chinese Academy of Medical Sciences (Grant Number 2022-GSP-GG-9).
Author information
Authors and Affiliations
Contributions
Wang C.Y., together with Wang J.X., Huang Y., and Zhang Y.H. proposed the research topic. Wang C.Y. and Wang J.X. designed the research program, implemented the research process, collected data, and performed the statistical analysis. All authors were responsible for drafting and revising the article based on the suggestions of Huang Y. and Zhang Y.H.Huang Y. and Zhang Y.H. reviewed the thesis, obtained research funding, and provided material support and academic guidance.
Corresponding authors
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wang, C., Wang, J., Li, X. et al. Associations between triglyceride-glucose index combined with waist circumference and heart failure in individuals with different body mass indices: a cross-sectional study using NHANES 2011–2020 data. Lipids Health Dis 24, 87 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02476-y
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12944-025-02476-y